Stockreport

Fresenius Kabi Further Expands Oncology Portfolio with Launch of Cyclophosphamide for Injection, USP [Yahoo! Finance]

FRESENIUS SE S/ADR  (FSNUY) 
NASDAQ:AMEX Investor Relations: fresenius.com/index
PDF LAKE ZURICH, Ill., February 28, 2024 BUSINESS WIRE )--Fresenius Kabi announced today it has introduced Cyclophosphamide for Injection, USP, a generic substitute for Cyt [Read more]